GO:0006231 dTMP biosynthetic process: One-Carbon Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006231 (dTMP biosynthetic process) describes the chemical reactions and pathways that produce deoxyribosylthymine monophosphate (dTMP), a direct precursor of DNA.
• The canonical route uses thymidylate synthase (TYMS) to transfer a methyl group from 5,10-methylenetetrahydrofolate to dUMP, producing dTMP and dihydrofolate.
• One-carbon metabolism, including the folate and vitamin B12 cycles, supplies the methyl groups and reducing equivalents required for dTMP synthesis [1,3].
• Alternative dTMP synthesis pathways exist in thermophilic bacteria and archaea, showing that this process is not universally dependent on the classical TYMS route.
• Compartmentalized thymidine salvage and phosphorylation, including mitochondrial TK2 and CMPK2, can contribute to dTMP pools in specific cellular contexts.
• Disruption of dTMP biosynthesis causes megaloblastic changes and is targeted by antifolate and fluoropyrimidine drugs in cancer and infectious disease [4,8].
Description
dTMP biosynthetic process (GO:0006231) is the set of biochemical reactions that generate deoxyribosylthymine monophosphate, the thymidine nucleotide used directly in DNA replication and repair. Because dTMP is the only deoxynucleoside monophosphate that is synthesized de novo from a ribonucleotide precursor rather than by simple reduction of a ribonucleotide, its production is a critical control point in nucleotide metabolism. The process is intimately linked to one-carbon metabolism, since the methyl group added to dUMP is derived from 5,10-methylenetetrahydrofolate, a central folate cofactor. Researchers study GO:0006231 because it connects folate status, vitamin B12 availability, and nucleotide supply to genome stability and cell proliferation [3,8]. Defects in this pathway produce megaloblastic anemia and are exploited by antifolate and fluoropyrimidine chemotherapies [4,8]. In addition, alternative dTMP synthesis routes in thermophilic bacteria and archaea highlight evolutionary diversity in how cells solve the same biochemical problem. Understanding dTMP biosynthesis therefore spans nutrition, cancer biology, microbiology, and drug development, making it a recurring target for CRISPR-based functional genomics and metabolic modeling [2,6].
dTMP biosynthetic process At A Glance
| GO ID | GO:0006231 |
|---|---|
| GO term | dTMP biosynthetic process |
| Ontology | biological_process |
| Synonym | dTMP anabolism; dTMP biosynthesis; dTMP formation; dTMP synthesis |
| Major function | Production of dTMP, the thymidine monophosphate precursor for DNA synthesis and repair |
| Key enzyme | Thymidylate synthase (TYMS) catalyzes the reductive methylation of dUMP to dTMP |
| Cofactor | 5,10-methylenetetrahydrofolate serves as the methyl donor and is oxidized to dihydrofolate |
| Pathway context | One-carbon metabolism, folate cycle, and nucleotide biosynthesis [1,3] |
| Compartment | Cytosol and nucleus, with mitochondrial salvage contributing to dTMP pools [2,6] |
What Is GO:0006231?
In simple terms, GO:0006231 describes how cells make dTMP, the thymine nucleotide building block of DNA. The QuickGO definition states that it is the chemical reactions and pathways resulting in the formation of dTMP, deoxyribosylthymine monophosphate (2'-deoxyribosylthymine 5'-phosphate). This includes the classical thymidylate synthase reaction and any alternative enzymatic routes that produce dTMP [2,5].
Why Is dTMP biosynthetic process Important in Cell Biology?
dTMP biosynthetic process is essential because it supplies the thymine nucleotide required for DNA replication and repair, and its disruption causes nucleotide imbalance, DNA damage, and cell cycle arrest. The pathway is a major node where folate and vitamin B12 status influence genome stability, and it is the target of widely used anticancer and antimicrobial drugs [4,8]. Consequently, GO:0006231 is relevant to cancer research, nutritional genomics, and the development of CRISPR-based disease models [1,6].
• Provides dTMP for DNA replication and repair, making it essential for cell proliferation.
• Links folate and vitamin B12 metabolism to nucleotide supply and genome stability.
• Dysregulation causes megaloblastic changes and contributes to anemia.
• Is the target of antifolate drugs such as methotrexate and fluoropyrimidines such as 5-fluorouracil.
• Alternative dTMP synthesis routes in thermophiles inform evolutionary and biotechnological studies.
• Mitochondrial thymidine phosphorylation by TK2 and CMPK2 can affect dTMP pools in specific tissues.
• Formate, a one-carbon carrier, influences dTMP synthesis through folate metabolism.
• CRISPR screens can identify genes required for dTMP biosynthesis and drug sensitivity.
What Happens During dTMP biosynthetic process?
Substrate generation: dUMP formation
In simple terms: First, the cell makes dUMP, the raw material that will be converted into dTMP.
dTMP biosynthesis begins with the availability of dUMP, which can be generated from dUTP by dUTPase or from deoxyuridine by thymidine kinase. In the classical pathway, dUMP is the direct substrate for thymidylate synthase, and its supply is tightly linked to nucleotide pool balance.
Methyl transfer by thymidylate synthase
In simple terms: An enzyme called thymidylate synthase adds a methyl group to dUMP to make dTMP.
Thymidylate synthase (TYMS) catalyzes the reductive methylation of dUMP to dTMP using 5,10-methylenetetrahydrofolate as both methyl donor and reductant. This reaction oxidizes the folate cofactor to dihydrofolate, which must be recycled by dihydrofolate reductase to sustain the pathway.
Folate cycle and one-carbon supply
In simple terms: The folate cycle recycles the used folate so that dTMP production can continue.
The methyl group used in dTMP synthesis is derived from serine and other one-carbon sources through the folate cycle. Dihydrofolate reductase regenerates tetrahydrofolate, and serine hydroxymethyltransferase converts serine to glycine while producing 5,10-methylenetetrahydrofolate [1,7]. Vitamin B12 and methionine synthase interconnect the folate and methionine cycles, influencing dTMP synthesis capacity.
Compartmentalization and salvage
In simple terms: Cells can also make dTMP in different compartments or recycle thymidine.
Nuclear and cytosolic dTMP synthesis are coordinated with DNA replication, and mitochondrial thymidine phosphorylation by TK2 and CMPK2 can contribute to dTMP pools in specific tissues [2,6]. Salvage pathways phosphorylate thymidine to dTMP, providing an alternative to de novo synthesis.
Alternative routes in thermophiles
In simple terms: Some heat-loving microbes use different enzymes to make dTMP.
Two distinct pathways for dTMP synthesis have been described in hyperthermophilic bacteria and archaea, demonstrating that the classical TYMS-dependent route is not universal. These alternative routes highlight evolutionary adaptation of nucleotide metabolism to extreme environments.
Key Genes Involved in GO:0006231 dTMP biosynthetic process
The following genes and proteins are experimentally implicated in dTMP biosynthetic process and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYMS | Thymidylate synthase; converts dUMP to dTMP using 5,10-methylenetetrahydrofolate | Primary target of fluoropyrimidine drugs; knockout causes thymineless death |
| DHFR | Dihydrofolate reductase; regenerates tetrahydrofolate for the folate cycle | Target of methotrexate; essential for sustained dTMP synthesis |
| MTHFR | Methylenetetrahydrofolate reductase; regulates folate distribution | Polymorphisms affect dTMP synthesis and drug response |
| MTR | Methionine synthase; links folate and methionine cycles via vitamin B12 | Vitamin B12 deficiency impairs dTMP synthesis |
| SHMT1 | Serine hydroxymethyltransferase; supplies one-carbon units | Contributes to 5,10-methylenetetrahydrofolate pools |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase; one-carbon source | Supports mitochondrial and cytosolic dTMP synthesis |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; folate interconversion | Affects formate and dTMP precursor supply |
| MTHFD2 | Mitochondrial one-carbon enzyme; supports nucleotide synthesis | Target in cancer metabolism studies |
| TYMP | Thymidine phosphorylase; thymidine catabolism and salvage | Modulates thymidine availability for dTMP salvage |
| TK1 | Thymidine kinase 1; salvage phosphorylation of thymidine | Cell cycle-regulated; marker of proliferation |
| TK2 | Thymidine kinase 2; mitochondrial thymidine phosphorylation | Mitochondrial dTMP pool maintenance |
| CMPK2 | Cytidine monophosphate kinase 2; phosphorylates thymidine monophosphate | Mitochondrial nucleotide homeostasis |
| DUT | dUTPase; produces dUMP for dTMP synthesis | Prevents uracil misincorporation into DNA |
| NT5C | Nucleotidase; dephosphorylates nucleotides | Regulates nucleotide pool balance |
| FPGS | Folylpolyglutamate synthetase; folate polyglutamation | Affects folate retention and dTMP synthesis |
| GGH | Gamma-glutamyl hydrolase; folate turnover | Modulates intracellular folate pools |
| SLC19A1 | Reduced folate carrier; folate uptake | Determines cellular folate availability |
| ATIC | AICAR transformylase; purine and folate metabolism | Interconnects purine and dTMP pathways |
How Is dTMP biosynthetic process Regulated?
dTMP biosynthetic process is regulated at multiple levels. TYMS expression is cell cycle-dependent, peaking in S phase to meet DNA replication demand. The pathway is also controlled by folate availability, with dihydrofolate reductase activity determining the recycling of dihydrofolate to tetrahydrofolate. Vitamin B12 status influences methionine synthase and the folate cycle, indirectly affecting dTMP synthesis. In addition, one-carbon metabolism is responsive to serine and formate supply, linking nutrient status to nucleotide production.
dTMP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYMS | Cancer drug resistance; fluoropyrimidine sensitivity [2,8] | TYMS knockout or point-mutation cancer cell lines |
| DHFR | Methotrexate resistance; megaloblastic anemia [1,4] | DHFR knockout and knock-in models |
| MTR | Vitamin B12 deficiency; megaloblastic anemia | MTR point-mutation cell models |
| TK2 | Mitochondrial DNA depletion syndrome | TK2 knockout or knock-in cells |
| CMPK2 | Mitochondrial nucleotide imbalance | CMPK2 overexpression and knockout models |
Megaloblastic anemia and nutritional deficiency
Impaired dTMP biosynthesis due to folate or vitamin B12 deficiency causes megaloblastic changes in hematopoietic cells, characterized by defective DNA synthesis and nuclear-cytoplasmic asynchrony [3,4]. Drug-induced megaloblastic change can also result from antifolate or other nucleotide-targeting therapies.
Cancer and chemotherapy response
Many cancers overexpress TYMS and other one-carbon enzymes to sustain proliferation, making dTMP biosynthesis a target of fluoropyrimidines and antifolates [2,8]. Resistance to these drugs often involves altered folate metabolism or TYMS expression.
Mitochondrial nucleotide disorders
Mutations affecting mitochondrial thymidine kinases such as TK2 and CMPK2 can disrupt mitochondrial dTMP pools and cause mitochondrial DNA depletion syndromes. These disorders highlight the importance of compartmentalized dTMP synthesis.
From dTMP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TYMS essential for proliferation? | TYMS knockout cell line |
| Does a TYMS point mutation alter drug binding? | TYMS point-mutation knock-in |
| How does DHFR expression affect dTMP synthesis? | DHFR overexpression and knockout |
| What is the role of mitochondrial TK2 in dTMP pools? | TK2 tagged knock-in and knockout |
| Can CRISPR screens identify new dTMP synthesis genes? | Genome-wide CRISPR knockout library screening |
| Does folate transporter loss affect dTMP synthesis? | SLC19A1 knockout cells |
How to Study the dTMP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | dTMP and nucleotide pool levels | Quantify pathway output after gene editing |
| Stable isotope tracing | One-carbon flux into dTMP | Assess folate-dependent synthesis |
| CRISPR knockout screen | Gene essentiality and drug sensitivity | Identify novel dTMP synthesis regulators |
| Enzyme activity assay | Thymidylate synthase activity | Test inhibitors or mutations |
| RNA-seq | Expression of one-carbon genes | Evaluate transcriptional response |
| Proteomics | Protein abundance and modifications | Detect pathway rewiring |
| Cell proliferation assay | Growth and viability | Measure impact of dTMP synthesis loss |
| Mitochondrial DNA copy number | Mitochondrial genome maintenance | Study TK2/CMPK2 models |
Metabolic labeling and nucleotide quantification
Stable isotope labeling with 13C-serine or 13C-formate followed by mass spectrometry can trace one-carbon flux into dTMP and related nucleotides. This approach quantifies pathway activity and identifies bottlenecks.
CRISPR functional genomics
Genome-wide CRISPR knockout screens can identify genes required for dTMP biosynthesis and sensitivity to antifolates. Validated hits can be studied with targeted knockouts or point mutations.
Enzyme activity assays
Thymidylate synthase activity can be measured in cell lysates using radiolabeled dUMP or spectrophotometric assays. These assays assess direct effects of mutations or inhibitors.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal expression changes in one-carbon and nucleotide metabolism genes under conditions of folate restriction or drug treatment [1,8]. Such data help contextualize dTMP synthesis within broader metabolic networks.
How CRISPR Can Be Used to Study GO:0006231 dTMP biosynthetic process
Knockout
CRISPR knockout of TYMS or DHFR can create cell models with impaired dTMP biosynthesis, useful for studying drug sensitivity and nucleotide stress. These models help validate gene essentiality and pathway dependencies.
Point Mutation
Point mutations in TYMS or DHFR can mimic clinical resistance alleles or alter catalytic activity, allowing precise structure-function studies [2,8]. Such models are valuable for testing targeted inhibitors.
Knock-in
Knock-in of tagged versions of TK2 or CMPK2 enables localization and interaction studies in mitochondrial dTMP metabolism. Tagged knock-ins also facilitate proteomic analysis of pathway complexes.
Overexpression
Overexpression of TYMS or one-carbon enzymes can model chemoresistance and increased dTMP synthesis capacity. These models are useful for screening combination therapies.
How EDITGENE Supports dTMP biosynthetic process Research
Researchers studying dTMP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, drug response, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for dTMP biosynthetic process research.
Frequently Asked Questions About dTMP biosynthetic process
What is dTMP biosynthetic process?
dTMP biosynthetic process (GO:0006231) is the set of reactions that produce dTMP, the thymidine nucleotide used in DNA synthesis, primarily through thymidylate synthase and folate-dependent one-carbon metabolism.
What genes are involved in dTMP biosynthetic process?
Key genes include TYMS, DHFR, MTHFR, MTR, SHMT1, SHMT2, MTHFD1, MTHFD2, TK1, TK2, CMPK2, and DUT, among others [1,2,6].
Why is dTMP synthesis important for cancer?
Many cancers depend on increased dTMP synthesis for proliferation, and drugs like 5-fluorouracil and methotrexate target this pathway [2,8].
How is dTMP synthesized?
The classical route converts dUMP to dTMP via thymidylate synthase using 5,10-methylenetetrahydrofolate as a methyl donor.
What is the role of folate in dTMP biosynthesis?
Folate derivatives supply the one-carbon units and methyl groups required for dTMP synthesis, linking diet and vitamin status to DNA synthesis [1,3].
Can dTMP be made without thymidylate synthase?
Yes, alternative pathways for dTMP synthesis exist in some thermophilic bacteria and archaea, and salvage pathways can also produce dTMP [5,6].
What diseases are linked to dTMP biosynthesis defects?
Folate or vitamin B12 deficiency causes megaloblastic anemia, and mitochondrial dTMP synthesis defects can cause mtDNA depletion syndromes [3,4,6].
How can I study dTMP biosynthetic process in the lab?
Common methods include LC-MS metabolomics, stable isotope tracing, enzyme activity assays, and CRISPR knockout screens [2,7].
What CRISPR models are available for dTMP synthesis genes?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as TYMS, DHFR, and TK2 [2,6].
What is the GO ID for dTMP biosynthetic process?
The GO ID is GO:0006231, under the biological_process ontology.
Conclusion
dTMP biosynthetic process (GO:0006231) is a central metabolic pathway that supplies the thymidine nucleotide for DNA synthesis and is tightly linked to folate and one-carbon metabolism [1,2]. Its dysfunction contributes to megaloblastic anemia, mitochondrial disorders, and cancer drug resistance, making it a key area for functional genomics [4,6,8]. CRISPR-based models and metabolic profiling provide powerful tools to dissect this pathway and identify new therapeutic opportunities [2,7].
References
- 1. Field MS et al.. 2018. Nuclear Folate Metabolism.. Annu Rev Nutr 38:219-243 PMID: 30130467
- 2. Chon J et al.. 2017. Targeting nuclear thymidylate biosynthesis.. Mol Aspects Med 53:48-56 PMID: 27876557
- 3. Shane B et al.. 1985. Vitamin B12-folate interrelationships.. Annu Rev Nutr 5:115-41 PMID: 3927946
- 4. Scott JM et al.. 1980. Drug-induced megaloblastic change.. Clin Haematol 9(3):587-606 PMID: 6450011
- 5. Leduc D et al.. 2004. Two distinct pathways for thymidylate (dTMP) synthesis in (hyper)thermophilic Bacteria and Archaea.. Biochem Soc Trans 32(Pt 2):231-5 PMID: 15046578
- 6. Ward AS et al.. 2025. Compartmentalized thymidine phosphorylation by mitochondrial nucleotide kinases TK2 and CMPK2.. J Biol Chem 301(11):110733 PMID: 40967432
- 7. Brosnan ME et al.. 2016. Formate: The Neglected Member of One-Carbon Metabolism.. Annu Rev Nutr 36:369-88 PMID: 27431368
- 8. Zheng Y et al.. 2019. Toward a better understanding of folate metabolism in health and disease.. J Exp Med 216(2):253-266 PMID: 30587505
